Anavex Life Sciences Corp (AVXL)

[jimmy667]

SAGE has built its 8.3 billion market cap largely on drugs that target GABA.
Mostly in depression another maybe even larger indication than Anavex indications but no more or less important.
Interesting note Dr. Andrew Cole possibly the pre-eminent researcher in Epliepsy of Cambridge MA as is SAGE and Biogen and many others is a member of SAGE and Anavex SAB and no others. Some might say a coincidence, but not a Detective for which there is no such thing as a coincidence in the dot connection of a deductive reasoning process.
Oh and possibly just a coincidence that SAGE is also Member of the Psyciatric Biomarker Consortium with Anavex and Cognition.
Further Cognition and Anavex share a patent on treatment protocol with the Cognition biomarker identification and deliniation technology which is the core of the Consortium efforts.
If one fails to see this they would not do well paning for gold. These dots are heavy shiny and valuable. Not dots to connect rather gold nuggets that need to recognized.